XML 41 R27.htm IDEA: XBRL DOCUMENT v3.6.0.2
Equity and Noncontrolling Interest
12 Months Ended
Dec. 31, 2016
Equity [Abstract]  
Stockholders' Equity Note Disclosure [Text Block]

In May 2015, the Company’s Board of Directors authorized a share repurchase program for the repurchase of up to $100.0 million of Quaker Chemical Corporation common stock (the “2015 Share Repurchase Program”). The 2015 Share Repurchase Program has no expiration date. The 2015 Share Repurchase Program provides a framework of conditions under which management can repurchase shares of the Company’s common stock. The Company currently intends to repurchase shares to at least offset the dilutive impact of shares issued each year as part of its employee benefit and share based compensation plans, and could repurchase more if the Company considers the share price to be at a level that offers an advantageous return for its shareholders. The purchases may be made in the open market or in private and negotiated transactions and will be in accordance with applicable laws, rules and regulations. In connection with the 2015 Share Repurchase Program, the remaining unutilized 1995 and 2005 Board of Directors authorized share repurchase programs were terminated.

In connection with the 2015 Share Repurchase Program, the Company acquired 83,879 shares of common stock for $5.9 million, during the year ended December 31, 2016, and 87,386 shares of common stock for $7.3 million during the year ended December 31, 2015. The Company has elected not to hold treasury shares and therefore has retired the shares as they are repurchased. It is the Company’s accounting policy to record the excess paid over par value as a reduction in retained earnings for all shares repurchased.

The Company has 30,000,000 shares of common stock authorized with a par value of $1, and 13,277,832 and 13,288,113 shares issued as of December 31, 2016 and 2015, respectively. The change in shares issued and outstanding during 2016 was primarily related to 83,879 shares repurchased in connection with the 2015 Share Repurchase Program offset by 55,982 shares issued for equity-based compensation plans, 6,130 shares issued for the ESPP and 11,486 shares issued for the exercise of stock options and other employee and director-related share activity.

Holders of record of the Company’s common stock for a period of less than 36 consecutive calendar months or less are entitled to one vote per share of common stock. Holders of record of the Company’s common stock for a period greater than 36 consecutive calendar months are entitled to 10 votes per share of common stock.

The Company is authorized to issue 10,000,000 shares of preferred stock with $1 par value, subject to approval by the Board of Directors. The Board of Directors may designate one or more series of preferred stock and the number of shares, rights, preferences, and limitations of each series. As of December 31, 2016, no preferred stock had been issued.

The following table shows the reclassifications from and resulting balances of AOCI for the years ended December 31, 2016, 2015 and 2014:

Unrealized
DefinedGain (Loss) in
CurrencyBenefitAvailable-for-
TranslationPensionSale
AdjustmentsPlansSecuritiesTotal
Balance at December 31, 2013$1,152$(37,433)$1,581$(34,700)
Other comprehensive (loss) income before reclassifications(15,464)(9,232)2,057(22,639)
Amounts reclassified from AOCI3,043(2,245)798
Related tax amounts2,071642,135
Balance at December 31, 2014(14,312)(41,551)1,457(54,406)
Other comprehensive (loss) income before reclassifications(24,232)5,057(850)(20,025)
Amounts reclassified from AOCI3,642(632)3,010
Related tax amounts(2,399)504(1,895)
Balance at December 31, 2015(38,544)(35,251)479(73,316)
Other comprehensive (loss) income before reclassifications(13,711)(4,229)834(17,106)
Amounts reclassified from AOCI3,075(17)3,058
Related tax amounts237(280)(43)
Balance at December 31, 2016$(52,255)$(36,168)$1,016$(87,407)

Approximately 30% and 70% of the amounts reclassified from accumulated other comprehensive loss to the Consolidated Statements of Income for defined benefit retirement plans during the years ended December 31, 2016, 2015 and 2014 were recorded in cost of goods sold and SG&A, respectively. See Note 17 of Notes to Consolidated Financial Statements for further information. All reclassifications related to unrealized gain (loss) in available-for-sale securities relate to the Company’s equity interest in a captive insurance company and are recorded in equity in net income of associated companies. The amounts reported on the Consolidated Statements of Changes in Equity for non-controlling interest are related to currency translation adjustments.